Your browser doesn't support javascript.
loading
Naltrexone Use in Treating Hypersexuality Induced by Dopamine Replacement Therapy: Impact of OPRM1 A/G Polymorphism on Its Effectiveness.
Verholleman, Audrey; Victorri-Vigneau, Caroline; Laforgue, Edouard; Derkinderen, Pascal; Verstuyft, Celine; Grall-Bronnec, Marie.
Affiliation
  • Verholleman A; Addictology and Psychiatry Department, CHU Nantes, 44093 Nantes, France.
  • Victorri-Vigneau C; Inserm UMR-1246, Université de Nantes, Université de Tours, 44200 Nantes, France.
  • Laforgue E; Pharmacology Department, CHU Nantes, 44093 Nantes, France.
  • Derkinderen P; Addictology and Psychiatry Department, CHU Nantes, 44093 Nantes, France.
  • Verstuyft C; Inserm UMR-1246, Université de Nantes, Université de Tours, 44200 Nantes, France.
  • Grall-Bronnec M; Pharmacology Department, CHU Nantes, 44093 Nantes, France.
Int J Mol Sci ; 21(8)2020 Apr 24.
Article in En | MEDLINE | ID: mdl-32344532

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sexual Dysfunction, Physiological / Dopamine / Sexuality / Disease Susceptibility / Naltrexone / Narcotic Antagonists Type of study: Systematic_reviews Limits: Animals / Humans Language: En Journal: Int J Mol Sci Year: 2020 Document type: Article Affiliation country: France Country of publication: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sexual Dysfunction, Physiological / Dopamine / Sexuality / Disease Susceptibility / Naltrexone / Narcotic Antagonists Type of study: Systematic_reviews Limits: Animals / Humans Language: En Journal: Int J Mol Sci Year: 2020 Document type: Article Affiliation country: France Country of publication: Switzerland